Concepedia

Hsiu-Chiung Yang

HY

3

Publications

567

Citations

3

H-Index

2017

Active since

Affiliations

Baylor College of Medicine(Current)

The University of Texas Medical Branch at Galveston

AstraZeneca (Sweden)

Hsiu-Chiung Yang is an author at Baylor College of Medicine specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

DiabetesMedicineMetabolic SyndromeImmunologyPharmacologyCell SignalingCardiovascular DiseaseHealthNephrologyPhysiology

Publications per year

2017–2020

3

Publications

3

SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

Yumei Ye, Mandeep Bajaj, Hsiu-Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2017 · 354 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +8

Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes

Yochai Birnbaum, Mandeep Bajaj, Hsiu-Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2018 · 124 citations

Inflammation, Metabolic Syndrome, Medicine +12

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

Huan Chen, Da T. Tran, Hsiu-Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2020 · 89 citations

Metabolic Syndrome, Cardiomyopathy, Insulin Signaling +15

Rows per page

1–3 of 3